So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| Đối chiếu điểm xu hướng để đánh giá chính sách× | Ghép cặp điểm xu hướng× | |
|---|---|---|
| Lĩnh vực≠ | Suy luận nhân quả | Thống kê nghiên cứu |
| Họ≠ | Regression model | Process / pipeline |
| Năm ra đời≠ | 1983; policy evaluation adaptation 1997 | 1983 |
| Người khởi xướng≠ | Rosenbaum & Rubin (1983); Heckman, Ichimura & Todd (1997) for program/policy evaluation application | Paul Rosenbaum and Donald Rubin |
| Loại≠ | Quasi-experimental matching estimator | Method |
| Công trình gốc≠ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41-55. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Tên gọi khác≠ | PSM policy evaluation, policy PSM, propensity matching for program evaluation, PSM treatment evaluation | PSM, propensity score weighting, covariate balance |
| Liên quan≠ | 6 | 3 |
| Tóm tắt≠ | Policy evaluation propensity score matching applies the propensity score framework — originally developed by Rosenbaum and Rubin (1983) and operationalized for program evaluation by Heckman et al. (1997) — to estimate the causal effect of a policy intervention. It constructs a credible comparison group from non-participants by matching them to participants on their estimated probability of receiving the treatment, enabling unbiased effect estimation without random assignment. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateBộ dữ liệu ↗ |
|
|